Related references
Note: Only part of the references are listed.Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: Alternative approaches for treatment of Type 2 diabetes
Faisal Malik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor
Francis S. Willard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors
Denise Wootten et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Activation of the GLP-1 receptor by a non-peptidic agonist
Peishen Zhao et al.
NATURE (2020)
Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme
Tina K. Thethi et al.
DIABETES OBESITY & METABOLISM (2020)
Full-length human GLP-1 receptor structure without orthosteric ligands
Fan Wu et al.
NATURE COMMUNICATIONS (2020)
Structural insights into the activation of GLP-1R by a small molecule agonist
Honglei Ma et al.
CELL RESEARCH (2020)
Structural insights into probe-dependent positive allosterism of the GLP-1 receptor
Ana B. Bueno et al.
NATURE CHEMICAL BIOLOGY (2020)
A combined activation mechanism for the glucagon receptor
Giulio Mattedi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structural insights into differences inGprotein activation by family Aand family BGPCRs
Daniel Hilger et al.
SCIENCE (2020)
GLP-1R agonists for the treatment of obesity: a patent review (2015-present)
Chunxia Liu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists
Xin Zhang et al.
MOLECULAR CELL (2020)
Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy
Jr Eugene E. Wright et al.
POSTGRADUATE MEDICINE (2020)
Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy
Jia Duan et al.
NATURE COMMUNICATIONS (2020)
Structural basis for activation of the growth hormone-releasing hormone receptor
Fulai Zhou et al.
NATURE COMMUNICATIONS (2020)
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
Takahiro Kawai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
Shoji Maeda et al.
SCIENCE (2019)
Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs
J. Bernard Heymann
PROTEIN SCIENCE (2018)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein
Yanyong Kang et al.
NATURE (2018)
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex
Yi-Lynn Liang et al.
NATURE (2018)
Development of an antibody fragment that stabilizes GPCR/G-protein complexes
Shoji Maeda et al.
NATURE COMMUNICATIONS (2018)
Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR-G Protein Complexes for Structure Determination
Yi-Lynn Liang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2018)
Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors
Yanting Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Crystal structure of the GLP-1 receptor bound to a peptide agonist
Ali Jazayeri et al.
NATURE (2017)
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Gaojie Song et al.
NATURE (2017)
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Yan Zhang et al.
NATURE (2017)
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Shawn Q. Zheng et al.
NATURE METHODS (2017)
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
Zin Z. Htike et al.
DIABETES OBESITY & METABOLISM (2017)
Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors
Li-Hua Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
Ana B. Bueno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Gctf: Real-time CTF determination and correction
Kai Zhang
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Structure of the adenosine A2A receptor bound to an engineered G protein
Byron Carpenter et al.
NATURE (2016)
An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain
Yanting Yin et al.
CELL DISCOVERY (2016)
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf et al.
PHARMACOLOGICAL REVIEWS (2016)
Conformational states of the full-length glucagon receptor
Linlin Yang et al.
NATURE COMMUNICATIONS (2015)
Differential Impact of Amino Acid Substitutions on Critical Residues of the Human Glucagon-Like Peptide-1 Receptor Involved in Peptide Activity and Small-Molecule Allostery
Cassandra Koole et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Francisco Kerr Saraiva et al.
CARDIOVASCULAR DIABETOLOGY (2014)
CHARMM-GUI Membrane Builder Toward Realistic Biological Membrane Simulations
Emilia L. Wu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2014)
A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification
Whitney M. Nolte et al.
NATURE CHEMICAL BIOLOGY (2014)
Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations
Denise Wootten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2013)
Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently
Ye-Hwang Cheong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
Francis S. Willard et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations
Wenbo Yu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Sjors H. W. Scheres
JOURNAL OF STRUCTURAL BIOLOGY (2012)
Targeting the glucagon receptor family for diabetes and obesity therapy
Young Min Cho et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2012)
CHARMM Additive All-Atom Force Field for Carbohydrate Derivatives and Its Utility in Polysaccharide and Carbohydrate-Protein Modeling
Olgun Guvench et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Crystal structure of the β2 adrenergic receptor-Gs protein complex
Soren G. F. Rasmussen et al.
NATURE (2011)
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
Kyle W. Sloop et al.
DIABETES (2010)
Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent Compound 2 at the GLP-1 Receptor
Karen Coopman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2010)
P-LINCS: A parallel linear constraint solver for molecular simulation
Berk Hess
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor
Min Teng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Small-molecule agonists for the glucagon-like peptide 1 receptor
Lotte Bjerre Knudsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors
TW Schwartz et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2006)
Mechanisms of peptide and nonpeptide ligand binding to class B G-protein coupled receptors
SRJ Hoare
DRUG DISCOVERY TODAY (2005)
Share Paper
